Clinical Trials Logo

Physical Inactivity clinical trials

View clinical trials related to Physical Inactivity.

Filter by:

NCT ID: NCT06274268 Not yet recruiting - Sarcopenia Clinical Trials

Effect of Sarcopenia on the Occurrence of Toxicity Related to Anti-cancer Treatments

SARC-ONCO
Start date: April 1, 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to learn about the effect of sarcopenic status on the occurrence of treatment-related toxicity during the first course of anti-cancer treatment in several types of cancers. The main question it aims to answer is : Is sarcopenia a predictive marker for the occurrence of toxicity in the initial phase of cancer treatment? The evaluation will focus on the body composition of the participants, assessed by impedancemetry, and on their muscular performance by standardized physical tests.

NCT ID: NCT06270641 Recruiting - Fatigue Clinical Trials

Increasing Physical Activity for Adults With Multiple Sclerosis (MS)

Start date: February 16, 2024
Phase: N/A
Study type: Interventional

This study aims to advance the scientific understanding and potential future implementation of physical activity promotion by testing the efficacy of a phone-based app for increasing activity in insufficiently active patients with multiple sclerosis (MS).

NCT ID: NCT06260995 Recruiting - Physical Inactivity Clinical Trials

The Role of Intermediaries in Connecting Individuals to Local Physical Activity - Study Protocol

Start date: September 1, 2023
Phase:
Study type: Observational

Intermediaries help people to connect to community-based services and supports, including physical activity and exercise groups (physical activities). They do this by acting as a link person. After receiving a referral or self-referral, they conduct an assessment, connect people to services in the community, and follow-up with people over time. This project will investigate if connecting to physical activities through an intermediary can improve health and wellbeing. It will also investigate people's experiences of working with an intermediary. This project is a pilot feasibility study, which means the investigators are evaluating the measures used and the way the trial is designed to see if they are suitable for a larger study in the future.

NCT ID: NCT06252259 Enrolling by invitation - Aging Clinical Trials

Evaluating Implementation and Impact of the Adapted Choose to Move (CTM) Program

CTM
Start date: June 15, 2024
Phase: N/A
Study type: Interventional

Choose to Move (CTM) is a 3-month, choice-based health-promoting program for low active older adults being scaled-up across British Columbia (BC), Canada. In Phase 5, the goal of CTM is to enhance physical activity, mobility and social connectedness in three target populations: South Asian older adults, older men, and older adults living in Northern BC. To do so, the investigators will support community-based seniors' services (CBSS) organizations through a readiness-building process so they can adapt CTM and deliver the program to these populations. This study has two main research questions: 1. How are adapted CTM programs delivered ('implementation outcomes') and what factors influence delivery ('implementation determinants')? 2. What is the impact of the adapted CTM programs on health outcomes of older adults?

NCT ID: NCT06246812 Completed - Physical Inactivity Clinical Trials

Text Message and Competition-Based Interventions Among University Students

Start date: September 19, 2022
Phase: N/A
Study type: Interventional

The goal of this quasi-experimental study is to assess and compare the effectiveness of text message interventions and a competition-based intervention and evaluate participants' acceptability and experiences in university students. The main questions it aims to answer are: 1. What are the effects of text message interventions and competition-based interventions on university students' physical activity levels, self-efficacy, self-regulation, social support, incentive motivation, and mental well-being? 2. What are participants' perceptions regarding their experience with and acceptability of text message interventions and competition-based interventions? Participants will 1. participate in a fitness competition 2. participate in a fitness competition and receive text messages 3. enroll in control group

NCT ID: NCT06242990 Recruiting - Physical Inactivity Clinical Trials

The Youth - Physical Activity Towards Health Intervention in Northern Ireland

Y-PATH NI
Start date: February 23, 2024
Phase: N/A
Study type: Interventional

The Y-PATH programme is an evidence-based intervention programme that has been found to be successful at increasing levels of physical activity in school children in the Republic of Ireland. The Irish Heart Foundation collaborated with Dublin City University and University College Cork to disseminate the programme nationally. The intervention programme aims to improve physical activity levels of adolescents through education about the importance of physical activity for health and the development of fundamental movement skills, which are basic movements associated with physical activity, such as, catching, throwing, and running. The main aims of the Y-PATH NI study are: - To explore Y-PATH as an intervention 'template', to lead the development of a research-informed model suitable for feasibility testing in a Northern Ireland context (Y-PATH NI). - To undertake feasibility testing of the Y-PATH NI multi-component intervention aimed at increasing moderate-to-vigorous physical activity in 11-14 year olds. - To conduct a process evaluation to determine primarily fidelity, but also acceptance and sustainability of the Y-PATH NI intervention.

NCT ID: NCT06242535 Active, not recruiting - Obesity Clinical Trials

Pilot Study of GLY-LOW Supplementation in Postmenopausal Women With Obesity

Start date: July 27, 2023
Phase: Early Phase 1
Study type: Interventional

A combination of generally regarded as safe (GRAS) compounds named GLY-LOW, which included: alpha lipoic acid, pyridoxamine, nicotinamide, piperine and thiamine, were examined in pre-clinical experiments. GLY-LOW supplementation reduced caloric intake and increased insulin sensitivity in mice. In female mice, GLY-LOW supplementation reversed aging-related declines in female hormones. Studies in humans are needed to examine the feasibility, utility and efficacy of GLY-LOW supplementation in post-menopausal women with obesity toward improving aging-related impairments. The effect of GLY-LOW supplementation on these obesity and biological age-related impairments in post-menopausal adult female humans with obesity is unknown. We aim to translate the findings of GLY-LOW supplementation in animals to a cohort of healthy, postmenopausal females at birth with obesity by conducting a one-group, no-placebo comparer, pre post intervention clinical trial. Additionally, we propose to examine the specific effect of supplementation by GLY-LOW on biological aging via retina scan. The objectives of the proposed pilot study are: I. Conduct a 6-month pilot study to examine the feasibility, utility and efficacy of GLY-LOW supplementation in a total of 40 postmenopausal female born adults > 55 years with obesity (> 30 BMI) Ia. Examine alterations in self-reported caloric intake and the following health and biological aging, parameters prior to and after 6 months of GLY-LOW supplementation: 1. Self-reported Caloric Intake 2. Metabolic disease risk 3. Cardiovascular disease risk 4. Metabolic assessments 5. Hormones 6. Physical Function and Fitness 7. Muscular strength 8. Cognitive Function and Depression assessments 9. Systemic inflammation 10. Biological aging 11. Safety parameters (also every 2 months during the intervention; ECG at baseline and 2 months only) 12, Compliance measures (pill counts and interviews every 2 months during the intervention)

NCT ID: NCT06242301 Recruiting - Physical Inactivity Clinical Trials

Is a Collective Person-centered Dialogue Intervention for Hospitalised COPD Patients Feasible?

COPE-D
Start date: January 15, 2024
Phase: N/A
Study type: Interventional

The aim of this mixed methods trial is to investigate the feasibility of a collective person-centred dialogue (COPE-D) intervention delivered by an interdisciplinary team for a population of patients hospitalised and diagnosed with COPD and their relatives. The main questions it aims to answer are: - The clinical uncertainties: What components of the COPE-D intervention are delivered to the included patients? (The data will be collected from the patient's journal record) - The clinical uncertainties: How acceptable is the COPE-D intervention for the patients, relatives, and the interdisciplinary team? (Answered by patient and relative interviews with a structured interview guide before discharge and 14 days after hospitalisation, and by the interdisciplinary team using focus-group interviews after the intervention enrolment). - The procedural uncertainties: Are the patients willing to engage in the trial? (Estimated by the inclusion rate). The interdisciplinary team will be instructed to deliver and document the COPE-D intervention. The primary focus of COPE-D intervention is to prepare and enhance the patient's and relative's ability to regain their everyday life after discharge. The COPE-D intervention includes a dialogue tool based on a needs assessment, an action plan template, and a patient guide that prepares for discharge. The interdisciplinary team will collaborate with COPD patients and their relatives to: 1. Assess the patient's need for nutrition and physical activity support, both during and after hospitalisation using the dialogue tool. 2. Develop an action plan for nutrition and physical activity support using the action plan template. 3. The interdisciplinary team will provide, adjust, and document the nutritional and physical activity support provided by the action plan. 4. Prior to discharge, patients and their relatives are given a discharge guide with pre-defined questions to ask healthcare professionals, a contact telephone number to the outpatient clinic for follow-up if needed, and information about prescriptions for oral nutritional supplementation.

NCT ID: NCT06225518 Not yet recruiting - Physical Inactivity Clinical Trials

The Effect of a Machine Learning-Based Mobile Application on Physical Activity in Overweight and Obese Women

Start date: May 4, 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to evaluate the effect of an algorithm-driven mobile application that provides personalized recommendations for increasing physical activity, which is an important health behavior, in the prevention of obesity and many other related non-communicable diseases in overweight and obese women. Hypotheses of this study are: - The physical activity level of overweight and obese adult women in the intervention group increases. - Body Mass Index decreases in overweight and obese adult women in the intervention group. - The daily step count of overweight and obese adult women in the intervention group increases. Participants will be asked to use the mobile application they received daily and follow their personalized physical activity program. Researchers will compare the experimental and control groups to see if the mobile application affected the physical activity level.

NCT ID: NCT06209424 Recruiting - Physical Inactivity Clinical Trials

Modified Breath Test to Determine Anabolic Sensitivity Across Physical Activity States

BTLP
Start date: January 15, 2024
Phase: N/A
Study type: Interventional

Developing tools to detect when our bodies are more resistant towards protein synthesis is valuable for identification of when someone may be at risk of losing body or muscle mass such as with aging or certain diseases. The current study aims to refine our previous breath test method to be more effective at measuring changes in how the body processes protein in different situations, such as resting, reducing physical activity, and doing resistance exercise. We hypothesize that using a lower amount of dietary amino acids in our breath test will be effective at detecting lower amounts of amino acids used after exercise, and a greater amount with step reduction compared to normal activity levels